H. Brunner-La Rocca

de Jong, M. B. L., Allach, Y., Kamar, S. A., Clephas, P. R. D., Brunner-La Rocca, H. P., Handoko, M. L., van de Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2026). The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring. Journal of Cardiac Failure, 32(4), 718-728. https://doi.org/10.1016/j.cardfail.2025.04.014

Ravassa, S., Girerd, N., Edelman, F., Lopez, B., Ferreira, J. P., Zurkan, D., Jose, G. S., Latasa, I., Pellicori, P., Cosmi, F., Petutschnigg, J., Heymans, S., Brunner-La Rocca, H.-P., Pieske, B., Delles, C., Clark, A. L., Diez, J., Zannad, F., Cleland, J. G. F., ... HOMAGE Trial Committees and Investigators (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), Article e70634. https://doi.org/10.1002/mco2.70634

Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429

Gilani, K., Wei, W., Peters, C., Verket, M., Brunner-La Rocca, H.-P., Nicolis, E., Colombo, M., Marx-Schutt, K., Urovi, V., & Dumontier, M. (2026). CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment. BMC Medical Informatics and Decision Making, 26(1), Article 8. https://doi.org/10.1186/s12911-025-03272-5

Herrmann, J. J., Van Berlo, R., Brunner-La Rocca, H.-P., Sanders-Van Wijk, S., Gommans, D. H. F., & Van Kimmenade, R. R. J. (2026). Fluid restriction in patients with heart failure: a systematic review. Heart. Advance online publication. https://doi.org/10.1136/heartjnl-2025-326784

Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4

Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651

Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5

Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5